Loading…
Reported covered position: Legislative Assistant, Rep. Wally Herger.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Defending American Jobs and Investment Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 7024, Tax Relief for American Families and Workers Act of 2024. H.R. 3665, The Defending America Jobs & Investment Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · first_quarter · Q1
Education related to products applicable to the military.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Source: Senate LDA
Tax Relief for American Families and Workers Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 7024, Tax Relief for American Families and Workers Act of 2024. H.R. 3665, The Defending America Jobs & Investment Act.
Defending American Jobs and Investment Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
Defending American Jobs and Investment Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
Defending American Jobs and Investment Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to medical device supply chains. Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
American Innovation and R&D Competitiveness Act of 2021
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
Consolidated Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Medical device shortage reporting provisions of S. 3799, PREVENT Pandemics Act and forthcoming MUDFA legislation.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
S.4264 - U.S. MADE Act of 2020. H.R. 8051 - US MADE Act of 2020.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Preventing Essential Medical Device Shortages Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology). FDA process for pre-approval inspections during COVID.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology).
S.4264 - U.S. MADE Act of 2020. H.R. 8051 - US MADE Act of 2020.
Issues related to U.S. subsidiaries of foreign companies in H.R.1., For the People Act of 2019.
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019. S.692 - Protect Medical Innovation Act of 2019. Issues related to Department of Treasury proposed regulation under IRC Section 382.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 2669, Medical Device Safety Act.
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019. S.692 - Protect Medical Innovation Act of 2019. Issues related to Department of Treasury proposed regulation under IRC Section 382.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
Medical Device Servicing Safety and Accountability Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
Medical Device Servicing Safety and Accountability Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
Medical Device Servicing Safety and Accountability Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52).
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
SUPPORT for Patients and Communities Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SUPPORT for Patients and Communities Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
Shiloh National Military Park Boundary Adjustment and Parker's Crossroads Battlefield Designation Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Foreign Agents Registration Amendments Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Foreign Agents Registration Amendments Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Foreign Agents Registration Amendments Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
Foreign Agents Registration Amendments Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code, including the House Blueprint.
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code.
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code.
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code, including the House Blueprint.
Protect Medical Innovation Act of 2018
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code.
Medical Device Access and Innovation Protection Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code, including the House Blueprint.
H.R. 7024, Tax Relief for American Families and Workers Act of 2024. H.R. 3665, The Defending America Jobs & Investment Act.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · fourth_quarter · Q4
Issues related to medical device supply chains. Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · third_quarter · Q3
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · second_quarter · Q2
Issues related to treatment of pressure injuries in Veterans Health Administration facilities. Education related to products applicable to the military.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
H.R. 3938, The Build it in America Act. H.R. 3665, The Defending America Jobs & Investment Act.
Issues related to procurement of medical technologies. Education related to products applicable to the military.
Issues related to U.S. subsidiaries of foreign owned companies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · first_quarter · Q1
Issues related to treatment of pressure injuries in Veterans Health Administration facilities. Education related to products applicable to the military.
Issues related to interest expense deductions under IRC section 163(j). Issues related to amortization of R+D expenses.
Issues related to U.S. subsidiaries of foreign owned companies.
Issues related to procurement of medical technologies. Education related to products applicable to the military.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. Medical device shortage reporting.
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · fourth_quarter · Q4
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices.
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · third_quarter · Q3
H.R. 5376, Inflation Reduction Act: Issues related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · second_quarter · Q2
Issues related to market access for medical devices in India and China.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · first_quarter · Q1
Issues related to market access for medical devices in India and China.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Medical device shortage reporting provisions of S. 3799, PREVENT Pandemics Act and forthcoming MUDFA legislation.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT). Issues related to amortization of R+D expenses (H.R. 1304, S. 749).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · fourth_quarter · Q4
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
Issues related to market access for medical devices in India and China.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · third_quarter · Q3
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
H.R. 5376, Build Back Better Act: Provisions related to interest expense deductions under IRC section 163(j), and proposed section 163(n). Provisions related to the Base Erosion and Anti-Abuse Tax (BEAT).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · second_quarter · Q2
Issues related to interest expense deductions under IRC section 163(j). Proposals to change the Base Erosion and Anti-Abuse Tax (BEAT) and other international tax provisions that impact foreign direct investment.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. FDA process for pre-approval inspections during COVID. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · first_quarter · Q1
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. FDA process for pre-approval inspections during COVID.
Issues related to interest expense deductions under IRC section 163(j).
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · fourth_quarter · Q4
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology). FDA process for pre-approval inspections during COVID.
Issues related to interest expense deductions under IRC section 163(j).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · third_quarter · Q3
S.4264 - U.S. MADE Act of 2020. H.R. 8051 - US MADE Act of 2020.
Issues related to market access for medical devices in India and China. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Issues related to market access for medical devices in India and China. Issues related to US tariffs on medical devices and patient access. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Issues related to interest deductions under IRC section 163(j) of the CARES Act (P.L. 116-136).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · first_quarter · Q1
Issues related to market access for medical devices in India. Issues related to US tariffs on medical devices and patient access. Issues related to World Trade Organization Government Procurement Agreement (GPA).
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · fourth_quarter · Q4
Issues related to market access for medical devices in India. Issues related to US tariffs on medical devices and patient access.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
H.R.2207 - Protect Medical Innovation Act of 2019. S.692 - Protect Medical Innovation Act of 2019. Issues related to Department of Treasury proposed regulation under IRC Section 382.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · third_quarter · Q3
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Issues related to section 101 of the Patent Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · second_quarter · Q2
Issues related to U.S. subsidiaries of foreign companies and the Foreign Agents Registration Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 2669, Medical Device Safety Act.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · first_quarter · Q1
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Issues related to U.S. subsidiaries of foreign companies in H.R.1., For the People Act of 2019.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · fourth_quarter · Q4
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · third_quarter · Q3
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · second_quarter · Q2
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52).
Issues related to Veterans Administration procurement.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · first_quarter · Q1
Issues related to market access for medical devices in India.
Issues related to Veterans Administration procurement.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · fourth_quarter · Q4
Issues related to Veterans Administration procurement.
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
Issues related to market access for medical devices in India and China. Issues related to trade agreements, including NAFTA, that impact medical technology.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · third_quarter · Q3
Issues related to market access for medical devices in India and China. Issues related to trade agreements, including NAFTA, that impact medical technology.
Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · second_quarter · Q2
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code, including the House Blueprint.
Issues related to market access for medical devices in India. Issues related to trade agreements, including NAFTA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to interest expense deductions under IRC section 163(j).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to Department of Treasury proposed regulation under IRC Section 382. Issues related to interest deductions under IRC section 163(j) of the CARES Act (P.L. 116-136). Issues related to the Further Consolidated Appropriations Act (P.L. 116-94).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Issues related to U.S. subsidiaries of foreign companies and the Foreign Agents Registration Act.
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
Issues related to market access for medical devices in India and the European Union. Issues related to US tariffs on medical devices and patient access.
Issues related to Veterans Administration procurement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and the European Union.
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Issues related to Veterans Administration procurement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to market access for medical devices in India and China.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)